For 2020, the International Psoriasis Council is pleased to announce the availability of five year-long fellowships through the IPC International Fellowship Program.
Meet the 2018 IPC International Fellows.
Meet the 2019 IPC International Fellows.
The International Fellowship Program aims to increase the number and ability of clinicians and scientists focused on researching and treating psoriasis. Beginning in January 2020, fellows will be matched with, and observe, IPC Board Members and Councilors in their clinics and laboratories to get real world practice in researching, diagnosing, developing treatment plans and monitoring treatment regiments for psoriasis patients. In addition, the program will provide an opportunity for IPC Fellows to develop on-going relationships with key opinion leaders by participating in IPC programs and activities throughout the one-year Fellowship period.
Fellowships are available to early career dermatologists in training or junior faculty who have completed their training within the last five years and are interested in improving their abilities to treat and manage psoriasis patients, gain exposure to international key opinion leaders and develop leadership skills among peers.
Complete the online application, uploading the following in PDF format:
Application for the 2020 Fellowships is now closed. Please check back in September 2020 for information about 2021 Fellowships.
Sites are available in Latin America, North America, Europe and Asia. IPC will provide the final site list to awarded fellows who will then select their top three choices. Final matches will be made by the Steering Committee, comprised of IPC Board Members and Councilors.
Learn more about the program
For questions about the IPC International Fellowship Program, please send an email to Fellowship@psoriasiscouncil.org.
Latest news July Update on PsoProtect Registry DataJuly 12, 2021Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,147 cases. Expert Opinion: Coronavirus disease 2019 (COVID‐19)‐associated hospitalization and mortality in patients with psoriasis: A population‐based studyJuly 07, 2021IPC Councilor, Luigi Naldi, MD, shares his expert opinion on a population-based study of COVID-19 - associated hospitalization and mortality in patients with psoriasis. Grand Rounds tutorial on IPC's psoriasis severity reclassificationJune 21, 2021The AbbVie program features IPC Board Member Bruce Strober’s Grand Rounds, a tutorial explaining the current method of measuring the severity of psoriasis, why this limits proper care and treatment for psoriasis patients, how IPC’s Disease Severity Reclassification Project solves these problems, and how clinicians can implement this new classification method. INSIDE LOOK campaign raises awareness about plaque psoriasisJune 16, 2021Amgen and Otezla® (apremilast) have partnered with Allan Avendaño, makeup artist to Hollywood A-listers, for the INSIDE LOOK campaign to share his journey living with plaque psoriasis and the difficulties of being in his demanding role and dealing with a chronic skin condition. More News